Noninvasive fetal RHD genotyping is an important tool for predicting RhD incompatibility between a pregnant woman and a fetus. This study aimed to assess a methodological approach other than the commonly used one for noninvasive fetal RHD genotyping on a representative set of RhD-negative pregnant women. The methodology must be accurate, reliable, and broadly available for implementation into routine clinical practice. A total of 337 RhD-negative pregnant women from the Czech Republic region were tested in this study. The fetal RHD genotype was assessed using two methods: real-time PCR and endpoint quantitative fluorescent (QF) PCR. We used exon-7-specific primers from the RHD gene, along with internal controls. Plasma samples were analyzed and measured in four/two parallel reactions to determine the accuracy of the RHD genotyping. The RHD genotype was verified using DNA analysis from a newborn buccal swab. Both methods showed an excellent ability to predict the RHD genotype. Real-time PCR achieved its greatest accuracy of 98.6% (97.1% sensitivity and 100% specificity (95% CI)) if all four PCRs were positive/negative. The QF PCR method also achieved its greatest accuracy of 99.4% (100% sensitivity and 98.6% specificity (95% CI)) if all the measurements were positive/negative. Both real-time PCR and QF PCR were reliable methods for precisely assessing the fetal RHD allele from the plasma of RhD-negative pregnant women.

Department of Blood Transfusion University Hospital and Palacky University Olomouc 775 20 Olomouc Czech Republic

Department of Medical Genetics University Hospital Olomouc and Faculty of Medicine and Dentistry Palacky University Olomouc 775 20 Olomouc Czech Republic

Department of Obstetrics and Gynecology University Hospital Olomouc and Faculty of Medicine and Dentistry Palacky University Olomouc 775 20 Olomouc Czech Republic

Institute of Biostatistics and Analyses Masaryk University 625 00 Brno Czech Republic

References provided by Crossref.org